https://www.selleckchem.com/
3%-100% at Week 4, 65.0%-67.9% at Week 24, and 33.8%-44.4% at Week 36. GAIS responder rate and FACE-Q appraisal of lines showed a similar pattern of change. Satisfaction was high and psychological well-being was improved from Week 4 through Week 36, with natural, youthful, and refreshed appearance reported for all ABO doses. A single ABO treatment (dosed at 50-125U) provided significant and sustained improvements in glabellar line severity over durations up to 36weeks, versus placebo. Treatment satisfaction was high with all doses. Participants reported nat
Like
Comment
Share
